Informative Value of Combination of Molecular Genetic and Cytogenetic Diagnostic Methods in Myelofibrosis
Introduction. Myelofibrosis is a rare disease affecting myeloid progenitor stem cells. According to the modern criteria of myelofibrosis diagnostics, the confirmation of the clonality of pathological myeloproliferative process is needed. However, the unique pathognomonic marker for this disease is n...
Saved in:
| Main Authors: | Lozynskyy R., Voronyak M., Poluben L., Dmytrenko I., Lozynska M., Vygovska Ya., Maslyak Z. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House "Kyrylytsya"
2016-07-01
|
| Series: | Львівський клінічний вісник |
| Subjects: | |
| Online Access: | http://lkv.biz/informative-value-of-combination-of-molecular-genetic-and-cytogenetic-diagnostic-methods-in-myelofibrosis/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possibilities of targeted therapy for myelofibrosis: Moscow experience
by: O. Yu. Vinogradova, et al.
Published: (2022-11-01) -
Targeted Therapy of Myelofibrosis
by: OYu Vinogradova, et al.
Published: (2017-10-01) -
Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study
by: O. Yu. Vinogradova, et al.
Published: (2024-09-01) -
Myelofibrosis Models: Literature Review and Own Data
by: AA Silyutina, et al.
Published: (2017-01-01) -
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
by: O. Yu. Vinogradova, et al.
Published: (2023-12-01)